Indeed, delivery of MTOR cDNA to the lung endothelium in mice with preexisting ALI resulted in reduced lung inflammation and injury, signifying the therapeutic potential of restoring EC-MTOR expression in the lung. The gene discussed is MTOR; the disease is acute respiratory distress syndrome.